Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Venook

Showing results (51-60 of 246) with videos related to

Pageof 25
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 8, 2011
Biomarker use in colorectal cancer therapyRobin K Kelley, Grace Wang, Alan P Venook
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Colorectal cancer: all hands on deckAlan P Venook, Martin R Weiser, Joel E Tepper
Surgical Oncology|April 12, 2003
Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisalBrendan C Visser, Alan P Venook, Marco G Patti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2014
Progress against GI cancer during the American Society of Clinical Oncology's first 50 yearsRobert J Mayer, Alan P Venook, Richard L Schilsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Special Series: Advances in GI CancerJeffrey A Meyerhardt, Joel E Tepper, Alan P Venook
Clinical Advances in Hematology & Oncology : H&O|September 21, 2005
Cetuximab in the treatment of colorectal cancerRichard M Goldberg, Alan P Venook, Richard L Schilsky
Surgical Oncology Clinics of North America|July 4, 2007
Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?Eric K Nakakura, Alan P Venook, Emily K Bergsland
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Is there currently an established role for the use of predictive or prognostic molecular markers in the management of colorectal cancer? A point/counterpointAlan P Venook, Johanna C Bendell, Robert S Warren
The Oncologist|December 1, 2010
Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?Riccardo Lencioni, Xiao-Ping Chen, Lucy Dagher, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal CancerAparna Parikh, Chloe Atreya, W Michael Korn, et al.
Pageof 25

Showing results (51-60 of 246) with videos related to

Sort By:
Pageof 25
Journal of the National Comprehensive Cancer Network : JNCCN|November 8, 2011
Biomarker use in colorectal cancer therapyRobin K Kelley, Grace Wang, Alan P Venook
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Colorectal cancer: all hands on deckAlan P Venook, Martin R Weiser, Joel E Tepper
Surgical Oncology|April 12, 2003
Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisalBrendan C Visser, Alan P Venook, Marco G Patti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2014
Progress against GI cancer during the American Society of Clinical Oncology's first 50 yearsRobert J Mayer, Alan P Venook, Richard L Schilsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Special Series: Advances in GI CancerJeffrey A Meyerhardt, Joel E Tepper, Alan P Venook
Clinical Advances in Hematology & Oncology : H&O|September 21, 2005
Cetuximab in the treatment of colorectal cancerRichard M Goldberg, Alan P Venook, Richard L Schilsky
Surgical Oncology Clinics of North America|July 4, 2007
Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?Eric K Nakakura, Alan P Venook, Emily K Bergsland
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Is there currently an established role for the use of predictive or prognostic molecular markers in the management of colorectal cancer? A point/counterpointAlan P Venook, Johanna C Bendell, Robert S Warren
The Oncologist|December 1, 2010
Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?Riccardo Lencioni, Xiao-Ping Chen, Lucy Dagher, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal CancerAparna Parikh, Chloe Atreya, W Michael Korn, et al.
Pageof 25